Source: Eur Respir J , 49 (2) 1601369; DOI: 10.1183/13993003.01369-2016
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Quentin Philippot, Aurélie Cazes, Raphaël Borie, Marie-Pierre Debray, Claire Danel, Maria Hurtado Nedelec, Sabah Boudjemaa, Déborah Sroussi, Clairelyne Dupin, Hervé Mal, Gaëlle Dauriat, Sylvain Jean-Baptiste, Gilles Jebrak, Yves Castier, Pierre Mordant, Gabriel Thabut, Olivier Brugière. Secondary pulmonary alveolar proteinosis after lung transplantation: a single-centre series. Eur Respir J , 49 (2) 1601369; DOI: 10.1183/13993003.01369-2016

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary alveolar proteinosis and GMSCF antibodies: a case series Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Pulmonary alveolar proteinosis: report of two cases Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Lung cysts in pulmonary alveolar proteinosis. Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Pulmonary alveolar proteinosis: from classification to therapy Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020 Year: 2020 Pulmonary alveolar proteinosis, study of 29 cases Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Novel method of whole lung lavage therapy using biphasic cuirass ventilator for pulmonary alveolar proteinosis; the retrospective observational study. Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Pulmonary alveolar proteinosis due to monocytopenia: Lung transplant or haematopoeitic stem cell transplant? Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 An open-label trial of rituximab therapy in pulmonary alveolar proteinosis Source: Eur Respir J 2011; 38: 1361-1367 Year: 2011 Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage Source: International Congress 2017 – Paediatric bronchology Year: 2017 Our cases with pulmonary alveolar proteinosis Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 Pulmonary alveolar proteinosis: A case report Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 Pulmonary alveolar proteinosis Source: Eur Respir Mon; 2009: 46: 208–224 Year: 2009 Pulmonary alveolar proteinosis Source: Eur Respir Rev 2011; 20: 98-107 Year: 2011 Pulmonary alveolar proteinosis therapy success with combined lavage procedures: a case report Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Pulmonary alveolar proteinosis Source: Respipedia Article Year: 2017 Whole lung lavage (WLL) in pulmonary alveolar proteinosis (PAP): long-term lung function follow-up Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003